Loibl, Sibylle <br/><br/>
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  Nov 2011 
 - 1789-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-010-1020-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--administration & dosage<br/>Drug Administration Schedule<br/>Epirubicin--administration & dosage<br/>Female<br/>Fever--prevention & control<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Leukopenia--chemically induced<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Paclitaxel--administration & dosage<br/>Polyethylene Glycols<br/>Prospective Studies<br/>Recombinant Proteins--administration & dosage<br/>Time Factors<br/>Young Adult